HC Wainwright & Co. analyst Mike Colonnese upgrades Cipher Mining (NASDAQ:CIFR) from Neutral to Buy and raises the price target from $1.5 to $3.
TrxADE Health Affirms Its Commitment To The Pharmaceutical Space Via Its Subsidiary TrxADE, Inc. Which Operates The Pharmaceutical Marketplace And Added More Members In Q3 Of 2023.
TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE"), a parent company of pharmaceutical business-to-business exchange platform, which recently merged with Superlatus, Inc. ("Superlatus"), today reconfirms its commitment to
